IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Q4 2025 Holdings

Filed 2026-02-11 | 8 holdings | $310.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MeiraGTx Holdings plc(MGTX)COMG59665102$97.0M12,197,73731.2%
Inhibrx Biosciences, Inc.(INBX)COM45720N103$91.5M1,157,92629.5%
Novavax(NVAX)COM NEW670002401$46.2M6,880,48114.9%
AnaptysBio(ANAB)COM032724106$39.8M821,91712.8%
Immuneering Corp(IMRX)CLASS A COM45254E107$17.8M2,708,5595.7%
MapLight Therapeutics Inc.(MPLT)COM56565P103$16.0M912,0415.2%
Eledon(ELDN)COM28617K101$1.2M814,9800.4%
Q32 Bio Inc.(QTTB)COM746964105$810.4K244,0830.3%